Literature DB >> 17635706

Cell-matrix adhesion in vascular development.

R O Hynes1.   

Abstract

Vascular development requires correct interactions among endothelial cells, pericytes and surrounding cells. These interactions involve many cell adhesion interactions, including cell-matrix interactions both with basement membranes and with surrounding extracellular matrices. Investigations of the contributions of these various interactions in vascular development and angiogenesis have been rather uneven and incomplete over the past 10-15 years. There has been considerable concentration on a few receptors, matrix proteins and proteolytic fragments with the goal of finding means to control angiogenesis. Many other potential contributors have received much less attention. Even for those molecules that have been subject to intensive investigation, our knowledge is incomplete. This review will survey the spectrum of extracellular matrix (ECM) proteins and cell-matrix adhesion receptors (particularly integrins) that are likely to contribute to angiogenesis and discuss what is known and not known about the roles of each of them.

Mesh:

Substances:

Year:  2007        PMID: 17635706     DOI: 10.1111/j.1538-7836.2007.02569.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  116 in total

Review 1.  Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization.

Authors:  Amber N Stratman; George E Davis
Journal:  Microsc Microanal       Date:  2011-12-14       Impact factor: 4.127

2.  Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Authors:  Sribalaji Lakshmikanthan; Magdalena Sobczak; Changzoon Chun; Angela Henschel; Jillian Dargatz; Ramani Ramchandran; Magdalena Chrzanowska-Wodnicka
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

3.  VEGF-induced vascular permeability is mediated by FAK.

Authors:  Xiao Lei Chen; Ju-Ock Nam; Christine Jean; Christine Lawson; Colin T Walsh; Erik Goka; Ssang-Taek Lim; Alok Tomar; Isabelle Tancioni; Sean Uryu; Jun-Lin Guan; Lisette M Acevedo; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  Dev Cell       Date:  2012-01-17       Impact factor: 12.270

Review 4.  Molecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matrices.

Authors:  Anastasia Sacharidou; Amber N Stratman; George E Davis
Journal:  Cells Tissues Organs       Date:  2011-10-13       Impact factor: 2.481

Review 5.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions.

Authors:  Richard O Hynes; Alexandra Naba
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

6.  The development of the vasculature and its extracellular matrix: a gradual process defined by sequential cellular and matrix remodeling events.

Authors:  George E Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

7.  Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development.

Authors:  Arjan van der Flier; Kwabena Badu-Nkansah; Charles A Whittaker; Denise Crowley; Roderick T Bronson; Adam Lacy-Hulbert; Richard O Hynes
Journal:  Development       Date:  2010-07       Impact factor: 6.868

Review 8.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

Review 9.  Cellular and molecular mechanisms underlying blood vessel lumen formation.

Authors:  Marta S Charpentier; Frank L Conlon
Journal:  Bioessays       Date:  2013-12-09       Impact factor: 4.345

10.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.